BRPI0908502A2 - aines oftálmicos como adjuvantes - Google Patents

aines oftálmicos como adjuvantes

Info

Publication number
BRPI0908502A2
BRPI0908502A2 BRPI0908502A BRPI0908502A BRPI0908502A2 BR PI0908502 A2 BRPI0908502 A2 BR PI0908502A2 BR PI0908502 A BRPI0908502 A BR PI0908502A BR PI0908502 A BRPI0908502 A BR PI0908502A BR PI0908502 A2 BRPI0908502 A2 BR PI0908502A2
Authority
BR
Brazil
Prior art keywords
aines
ophthalmic
adjuvants
ophthalmic aines
Prior art date
Application number
BRPI0908502A
Other languages
English (en)
Inventor
Simon P Chandler
Tetsuo Kida
Tim Mcnamara
Original Assignee
Ista Pharmaceuticals
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ista Pharmaceuticals, Senju Pharma Co filed Critical Ista Pharmaceuticals
Publication of BRPI0908502A2 publication Critical patent/BRPI0908502A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BRPI0908502A 2008-02-21 2009-02-19 aines oftálmicos como adjuvantes BRPI0908502A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3046408P 2008-02-21 2008-02-21
PCT/US2009/034511 WO2009105534A2 (en) 2008-02-21 2009-02-19 Ophthalmic nsaids as adjuvants

Publications (1)

Publication Number Publication Date
BRPI0908502A2 true BRPI0908502A2 (pt) 2017-05-23

Family

ID=40986176

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0908502A BRPI0908502A2 (pt) 2008-02-21 2009-02-19 aines oftálmicos como adjuvantes

Country Status (10)

Country Link
US (1) US20110054031A1 (pt)
EP (1) EP2247289A4 (pt)
JP (1) JP2011513229A (pt)
KR (1) KR20100135748A (pt)
CN (1) CN101965183A (pt)
BR (1) BRPI0908502A2 (pt)
CA (1) CA2716110A1 (pt)
RU (1) RU2010138799A (pt)
TW (1) TW200940052A (pt)
WO (1) WO2009105534A2 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
BR112013009205A2 (pt) 2010-10-15 2016-07-26 Iscience Interventional Corp dispositivo para colocação na esclera de um olho, método para acessar o espaço supracoroidal de um olho, para acessar o espaço subretinal de um olho e para colocar um orifício dentro de um trato escleral em um olho.
TW202023575A (zh) * 2011-09-16 2020-07-01 美商遠景生物製藥股份有限公司 安定之普維酮—碘組成物
EP2765988A1 (en) 2011-10-12 2014-08-20 Bausch & Lomb Incorporated Ocular composition containing bromfenac with increased bioavailability
TW201323425A (zh) * 2011-11-04 2013-06-16 Alcon Res Ltd 抗菌性咔啉化合物
CN102641242B (zh) * 2012-03-19 2013-10-16 孙猛 一种复合磷脂固醇脂质的制备方法
TWI604858B (zh) * 2012-03-28 2017-11-11 參天製藥股份有限公司 含有２－胺基－３－（４－溴苯甲醯基）苯基醋酸之水性組成物及其製造方法
EP2916827B1 (en) 2012-11-08 2020-06-10 Clearside Biomedical Inc. Methods for the treatment of ocular disease in human subjects
MY185551A (en) * 2013-03-13 2021-05-19 Genentech Inc Antibody formulations
CN105555363B (zh) * 2013-05-06 2019-03-12 长庚医疗财团法人高雄长庚纪念医院 医药组成物及其用途
EP3013790A1 (en) 2013-06-27 2016-05-04 Mylan Laboratories Ltd. Process for the preparation of nepafenac
WO2015004616A1 (en) * 2013-07-11 2015-01-15 Novartis Ag Use of a vegf antagonist in treating chorioretinal neovascular and permeability disorders in paediatric patients
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
JP6867288B2 (ja) 2014-07-21 2021-04-28 エーエムディー セラピューティックス エルエルシー リファマイシンの眼科用組成物およびその使用
ES2949173T3 (es) 2014-09-15 2023-09-26 Hoffmann La Roche Formulaciones de anticuerpo
CN104352487B (zh) * 2014-11-20 2016-04-13 张学印 一种防治视网膜病变的药用制剂及其应用
RU2744860C2 (ru) 2015-12-30 2021-03-16 Кодиак Сайенсиз Инк. Антитела и их конъюгаты
WO2017192565A1 (en) 2016-05-02 2017-11-09 Clearside Biomedical, Inc. Systems and methods for ocular drug delivery
CA3072847A1 (en) 2016-08-12 2018-02-15 Clearside Biomedical, Inc. Devices and methods for adjusting the insertion depth of a needle for medicament delivery
EP4046609A1 (en) * 2016-09-30 2022-08-24 Mati Therapeutics Inc. Ophthalmic drug sustained release formulation and uses thereof
EP4041312A4 (en) 2019-10-10 2023-12-20 Kodiak Sciences Inc. METHOD FOR TREATING AN EYE DISORDER
WO2021262715A1 (en) * 2020-06-23 2021-12-30 Anovent Pharmaceutical (U.S.), Llc Pharmaceutical formulation containing active metabolites of remdesivir or its analog for inhalation
CN114224830A (zh) * 2021-12-24 2022-03-25 辰欣药业股份有限公司 一种单剂量无抑菌剂的眼用制剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH577461A5 (pt) * 1975-08-13 1976-07-15 Robins Co Inc A H
US4910225A (en) * 1988-01-27 1990-03-20 Senju Pharmaceutical Co., Ltd. Locally administrable therapeutic composition for inflammatory disease
US5603929A (en) * 1994-11-16 1997-02-18 Alcon Laboratories, Inc. Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
AR030345A1 (es) * 2000-08-14 2003-08-20 Alcon Inc Metodo de tratamiento de desordenes relacionados con angiogenesis
WO2004064828A1 (ja) * 2003-01-21 2004-08-05 Senju Pharmaceutical Co., Ltd. ２−アミノ−３−(４−ブロモベンゾイル)フェニル酢酸含有水性液剤
WO2006056889A2 (en) * 2004-10-06 2006-06-01 Tiltan Pharma Ltd Method and composition for enhancing anti-angiogenic therapy
US20060134226A1 (en) * 2004-11-16 2006-06-22 Todd Leonard Compositions useful to treat ocular neovascular diseases and macular degeneration
WO2007038453A2 (en) * 2005-09-26 2007-04-05 Advanced Ocular Systems Limited Use of an anti-vascular endothelial growth factor (vegf) agent to ameliorate inflammation
US8168584B2 (en) * 2005-10-08 2012-05-01 Potentia Pharmaceuticals, Inc. Methods of treating age-related macular degeneration by compstatin and analogs thereof
US20070196350A1 (en) * 2006-02-22 2007-08-23 Bartels Stephen P Compositions and Methods for Effecting Controlled Posterior Vitreous Detachment

Also Published As

Publication number Publication date
WO2009105534A2 (en) 2009-08-27
TW200940052A (en) 2009-10-01
RU2010138799A (ru) 2012-03-27
CN101965183A (zh) 2011-02-02
JP2011513229A (ja) 2011-04-28
CA2716110A1 (en) 2009-08-27
EP2247289A4 (en) 2011-05-04
WO2009105534A3 (en) 2009-11-05
KR20100135748A (ko) 2010-12-27
US20110054031A1 (en) 2011-03-03
EP2247289A2 (en) 2010-11-10

Similar Documents

Publication Publication Date Title
BRPI0908502A2 (pt) aines oftálmicos como adjuvantes
SMT201500053B (it) 2-Amminobenzimidazol-5-carbossammidi come agenti nati-infiammatori
BRPI0922845A2 (pt) pirazol-4-n-alcoxicarboxamidas como microbiocidas
DK2539015T3 (da) Nethindeprotese
BR112013003245A2 (pt) derivados de heteroarilpiperidina e -piperazina como fungicidas
BRPI1009281A2 (pt) composição oftálmica tópica
BRPI0924142A2 (pt) colheitadeiras combinadas
BRPI1014077A2 (pt) Derivados de tiazolilperidina como fungicidas
FR2946492B3 (fr) Coupe-herbe
FI20095433A0 (fi) Mikroneula
BRPI1014398A2 (pt) roçadora
BRPI1009465A2 (pt) Formulação
IT1395844B1 (it) Tagliaerba
FR2934751B1 (fr) Tondeuse de type autoportee
IT1403453B1 (it) Protesi retinica
DK2520150T3 (da) Slåindretning
BR112012015386A2 (pt) composição oftálmica tópica
BR112012003320A2 (pt) ceifeira combinada
FR2943937B1 (fr) Tondeuse corporelle aspirante
FR2940007B1 (fr) Taille-haie
DK2590565T3 (da) Blodprøvetagning
BRPI0918062A2 (pt) Tienilaminopirimidinas como fungicidas
DK2467136T3 (da) 4-methylpyrazolformuleringer
DK2279652T3 (da) Kultivator
BRPI1013462A2 (pt) Formulações herbicidas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]